Knight Therapeutics (TSX:GUD) Inventories, Finished Goods : C$0.0 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Inventories, Finished Goods?

Knight Therapeutics's quarterly finished goods declined from Sep. 2023 (C$97.8 Mil) to Dec. 2023 (C$80.4 Mil) and declined from Dec. 2023 (C$80.4 Mil) to Mar. 2024 (C$0.0 Mil).

Knight Therapeutics's annual finished goods increased from Dec. 2021 (C$58.8 Mil) to Dec. 2022 (C$79.2 Mil) and increased from Dec. 2022 (C$79.2 Mil) to Dec. 2023 (C$80.4 Mil).

Knight Therapeutics Inventories, Finished Goods Historical Data

The historical data trend for Knight Therapeutics's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Inventories, Finished Goods Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

56.63

40.45

58.82

79.22

80.42

Knight Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															87.14	84.55	97.82	80.42	-

Knight Therapeutics Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Knight Therapeutics (TSX:GUD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

KHTRF:USA

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Executives

Sime Armoyan

10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines